H1 2017 Ankylosing Spondylitis Pipeline Overview of Market Companies and Drug Profile Report


Posted June 2, 2017 by justinebiel

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2017, provides an overview of the Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders) pipeline landscape.

 
H1 Ankylosing Spondylitis pipeline report evaluates Ankylosing Spondylitis (Bekhterev’s Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

Main key players of Ankylosing Spondylitis pipeline are AbbVie Inc, Adello Biologics LLC, Allergan Plc, Alteogen Inc, Amgen Inc, Biocad, Biocon Ltd, Bionovis SA, Celgene Corp, Coherus BioSciences Inc, Galapagos NV, Genor BioPharma Co Ltd, Immunwork Inc, Innovent Biologics Inc, Johnson & Johnson, Merck KGaA, Momenta Pharmaceuticals Inc, Mycenax Biotech Inc, Novartis AG, Oncobiologics Inc, Protalix BioTherapeutics Inc, Reliance Life Sciences Pvt Ltd, Sandoz International GmbH, Shanghai Pharmaceutical Co Ltd, Sun Pharma Advanced Research Company Ltd, UCB SA, Xbrane Biopharma AB.

Ankylosing spondylitis is a type of arthritis that affects the spine. Ankylosing spondylitis symptoms include pain and stiffness from the neck down to the lower back. The spine's bones (vertebrae) may grow or fuse together, resulting in a rigid spine. These changes may be mild or severe, and may lead to a stooped-over posture.

Discount Available at http://www.reportsnreports.com/contacts/discount.aspx?name=1020039 (This report is available at upto 25% Discount till June 02nd 2017.)

Ankylosing Spondylitis - Drug Profiles are apremilast, BAT-1406, BCD-085, bimekizumab, certolizumab pegol biosimilar, DNX-114, DNX-514, etanercept biosimilar, filgotinib, golimumab, HEISCO-III-002, infliximab biosimilar, risankizumab, secukinumab, TE-2122, TE-2158, thalidomide, tildrakizumab, upadacitinib tartrate, VTP-43742

Ankylosing Spondylitis - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Ankylosing Spondylitis (Bekhterev’s Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Order a copy of this research report at http://www.reportsnreports.com/purchase.aspx?name=1020039

Scope
• The pipeline guide provides a snapshot of the global therapeutic landscape of Ankylosing Spondylitis (Bekhterev’s Disease).
• The pipeline guide reviews pipeline therapeutics for Ankylosing Spondylitis (Bekhterev’s Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
• The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
• The pipeline guide reviews key companies involved in Ankylosing Spondylitis (Bekhterev’s Disease) therapeutics and enlists all their major and minor projects.
• The pipeline guide evaluates Ankylosing Spondylitis (Bekhterev’s Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
• The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
• The pipeline guide reviews latest news related to pipeline therapeutics for Ankylosing Spondylitis (Bekhterev’s Disease)

List of Figures
Number of Products under Development for Ankylosing Spondylitis (Bekhterev's Disease), H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products by Top 10 Targets, H1 2017
Number of Products by Stage and Top 10 Targets, H1 2017
Number of Products by Top 10 Mechanism of Actions, H1 2017
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
Number of Products by Routes of Administration, H1 2017
Number of Products by Stage and Routes of Administration, H1 2017
Number of Products by Molecule Types, H1 2017
Number of Products by Stage and Molecule Types, H1 2017

About Us:
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Call +1 888 391 5441 with your research requirements or email the details at [email protected] and we would be happy to help you find the business intelligence that you need. ReportsnReports.com offers research studies on agriculture, energy and power, automotive, Semiconductor and Electronics, Manufacturing & Construction, chemicals, environment, medical devices, healthcare, food and beverages, water and much more.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By justinebiel
Country India
Categories Health , Industry , News
Tags ankylosing spondylitis , ankylosing spondylitis market , ankylosing spondylitis pipeline , ankylosing spondylitis report
Last Updated June 2, 2017